The Effect on Cognition of Mitochondrial Respiratory System Proteins in Peripheral Blood Mononuclear Cells in the Course of Lung Cancer

Abstract

Peripheral blood mononuclear cells (PBMC) represent an easily available population of cells for the studies on remote effects of lung cancer. NADH dehydrogenase (ubiquinone) Fe-S protein-1 (Ndufs1), a marker of mitochondrial complex I, and mitochondrially encoded cytochrome c oxidase 1 (MTCO1), a marker of complex IV, may participate in cognitive decline during the course of lung cancer. In this study, Ndufs1 and MTCO1 expression in PBMC was evaluated by means of ELISA in 80 lung cancer patients. Mini-Mental State Examination (MMSE) were conducted Trail Making Tests (TMT-A and TMT-B) at baseline and after the 6 months' follow-up. Autoantibodies were identified by means of indirect immunofluorescence and line blot. We found that enhanced levels of Ndufs1 in PBMC were related to impaired cognitive performance; TMT-A of 13.6 ± 3.1 s and TMT-B of 162.5 ± 46.4 s compared with 8.6 ± 4.5 s (p = 0.003) and 124.8 ± 51.8 s (p < 0.05), respectively, in the case of low Ndufs-1 levels. The Ndufs1 expression at baseline was associated with MMSE - τb (Kendall's tau-b) = -0.31; p = 0.024; TMT-A - τb = 0.30; p = 0.001), and TMT-B - τb = 0.199; p = 0.012) after the 6 months' follow-up. Higher MTCO1 expression was accompanied by worse TMT-A results than in case of inhibited MTCO1; 11.1 ± 5.8 s vs. 8.5 ± 4.1 s; respectively; p = 0.048. MTCO1 expression was correlated with TMT-A results (τb = 0.17; p = 0.034) at baseline. We conclude that stimulation of PBMC mitochondrial function in lung cancer patients is associated with cognitive impairment. Mitochondrial dysfunction in PBMC may reflect cytotoxicity responsible for neurological deficits.

Quantitative analysis of the mitochondrial proteome in human ovarian carcinomas

“…The role of mitochondrial ribosomal protein S23 (MRPS23) in carcinoma cell proliferation could be a potential therapeutic target, in case of interference of hepatocellular cancer proliferation, oncogenesis and metastasis (Pu et al 2017). The expression of COX1 was involved in endometrial cancers (Ksiezakowska-Lakoma et al 2017), esophageal adenocarcinoma (Huhta et al 2017) and lung cancer (Michalak et al 2016). Taken all together, these examples support the notion that mitochondria contribute to the angiogenetic, tumorigenic, proliferation, invasive and metastatic features of cancer cells.…”

Comprehensive analyses of Disulfidptosis-related genes on prognosis and immune infiltration in lung adenocarcinoma

“…It suggested that SLC3A2, SLC7A11 held the highest diagnostic value. In LUAD patients, previous studies have suggested that NDUSF1 was associated with invasion and cognitive impairment, and was a potential therapeutic target [38,39]. High expression of LRPPRC was associated to poor prognosis and down-regulation of LRPPRC could meliorate drug resistance of LUAC [40].…”

Mitochondrial Proteomic and Molecular Network Alterations in Human Ovarian Cancers

“…MRPS15 is significantly upregulated in epithelial breast cells and tissues [10]. Mitochondrial COX1 is expressed abnormally in multiple cancers [11][12][13]. Many cancer-relevant communication signaling pathways are linked to mitochondrial proteins.…”